Back
Novonesis AS 10K Form
Sell
47
NVZMY
Novonesis AS
Last Price:
54.46
Seasonality Move:
3.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVZMY News And Ratings
See the #1 stock for the next 7 days that we like better than NVZMY
NVZMY Financial Statistics
Sales & Book Value
| Annual Sales: | $2.6B |
|---|---|
| Cash Flow: | $73.87M |
| Price / Cash Flow: | 50.11 |
| Annual Sales: | $7.48 |
| Price / Book: | 12.27 |
Profitability
| EPS (TTM): | 1.57970 |
|---|---|
| Net Income (TTM): | $439.06M |
| Gross Margin: | $1.41B |
| Return on Equity: | 21.43% |
| Return on Assets: | 10.69% |
Novonesis AS Earnings Forecast
Key Novonesis AS Financial Ratios
- The Gross Profit Margin over the past 22 years for NVZMY is 54.32%.
- The Selling, General & Administrative Expenses for NVZMY have been equal to 18.57% of Gross Profit Margin.
- The Research & Development expenses have been 11.27% of Revenue.
- The Interest Expense is 5.72% of Operating Income.
- The Net Earning history of NVZMY is 16.89% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 17 years.
Novonesis AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | NVZMY |
| Website: | novozymes.com |
Debt
| Debt-to-Equity Ratio: | 0.53 |
|---|---|
| Current Ratio: | 1.3 |
| Quick Ratio: | 0.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.73 |
|---|---|
| Forward P/E Ratio: | 0 |
NVZMY Technical Analysis vs Fundamental Analysis
Sell
47
Novonesis AS (NVZMY)
is a Sell
Is Novonesis AS a Buy or a Sell?
-
Novonesis AS stock is rated a Sell
The current Novonesis AS [NVZMY] share price is $54.86. The Score for NVZMY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.